

{{Drugbox
| Watchedfields = changed
| verifiedrevid = 464194334
| IUPAC_name = 4-amino-5-chloro-''N''-(2-(diethylamino)ethyl)-2-methoxybenzamide
| image = Metoclopramide.svg
| width = 225px
| image2 = Metoclofinal.png
| width2 = 225px

<!--Clinical data-->
| pronounce = {{IPAc-en|ˌ|m|ɛ|t|ə|ˈ|k|l|ɒ|p|r|ə|m|aɪ|d}}
| tradename = REGLAN, Reglan, {{tsl|en|||others}}<ref name=generics/>
| Drugs.com = {{drugs.com|monograph|metoclopramide-hydrochloride}}
| MedlinePlus = a684035
| pregnancy_AU = A
| pregnancy_US = B
| legal_AU = S3 (combination with paracetamol), S4 (alone)
| legal_CA = Rx-only
| legal_US = Rx-only
| licence_US = Metoclopramide
| legal_UK = POM
| routes_of_administration = [[口服给药|By mouth]], [[靜脈注射|intravenous]], [[肌肉注射|intramuscular]]
| class = [[Dopamine_antagonist|D<sub>2</sub> receptor antagonist]]; {{tsl|en|Serotonin antagonist||5-HT<sub>3</sub> receptor antagonist}}; [[血清素受體激動劑|5-HT<sub>4</sub> receptor agonist]]; {{tsl|en|Prolactin releaser||Prolactin releaser}}

<!--Pharmacokinetic data-->
| bioavailability = 80 ± 15% (by mouth)
| protein_bound = 
| metabolism = [[肝臟|Liver]]
| elimination_half-life = 5–6 hours
| excretion = [[尿|Urine]]: 70–85%<br />[[糞便|Feces]]: 2%

<!--Identifiers-->
| CAS_number_Ref = {{cascite|correct|??}}
| CAS_number = 364-62-5
| ATC_prefix = A03
| ATC_suffix = FA01
| PubChem = 4168
| IUPHAR_ligand = 241
| DrugBank_Ref = {{drugbankcite|correct|drugbank}}
| DrugBank = DB01233
| ChemSpiderID_Ref = {{chemspidercite|correct|chemspider}}
| ChemSpiderID = 4024
| UNII_Ref = {{fdacite|correct|FDA}}
| UNII = L4YEB44I46
| KEGG_Ref = {{keggcite|correct|kegg}}
| KEGG = D00726
| ChEBI_Ref = {{ebicite|correct|EBI}}
| ChEBI = 107736
| ChEMBL_Ref = {{ebicite|correct|EBI}}
| ChEMBL = 86
| synonyms =

<!--Chemical data-->
| C=14 | H=22 | Cl=1 | N=3 | O=2
| molecular_weight = 299.80 g/mol
| SMILES = Clc1cc(c(OC)cc1N)C(=O)NCCN(CC)CC
| StdInChI_Ref = {{stdinchicite|correct|chemspider}}
| StdInChI = 1S/C14H22ClN3O2/c1-4-18(5-2)7-6-17-14(19)10-8-11(15)12(16)9-13(10)20-3/h8-9H,4-7,16H2,1-3H3,(H,17,19)
| StdInChIKey_Ref = {{stdinchicite|correct|chemspider}}
| StdInChIKey = TTWJBBZEZQICBI-UHFFFAOYSA-N

<!--Physical data-->
| melting_point = 147.3
}}
<!-- Definition and medical uses -->
'''甲氧氯普胺'''（Metoclopramide）適用於治療[[胃|胃]]及[[食道|食道]]問題的藥物<ref>{{cite web|title=Metoclopramide|url=https://www.nlm.nih.gov/medlineplus/druginfo/meds/a684035.html|website=Nlm.nih.gov|accessdate=28 September 2014}}</ref>。本品主要用於治療[[恶心|恶心]]和[[呕吐|呕吐]]，並可協助{{tsl|en|gastroparesis|胃輕癱|胃排空}}障礙的患者排空胃部，並治療[[胃食道逆流|胃食道逆流]]<ref name=AHFS>{{cite web | title = Metoclopramide hydrochloride | work = Monograph| url =https://www.drugs.com/monograph/metoclopramide-hydrochloride.html | publisher = The American Society of Health-System Pharmacists| accessdate = 2014-09-27}}</ref>。本品也可以用於治療[[偏頭痛|偏頭痛]]<ref>{{cite journal|last1=Becker|first1=WJ|title=Acute Migraine Treatment in Adults.|journal=Headache|date=June 2015|volume=55|issue=6|pages=778–93|pmid=25877672|doi=10.1111/head.12550}}</ref>，並可治療{{tsl|en|gastroparesis|胃輕癱}}。


<!-- Side effects -->
常見副作用包含，疲累、[[腹瀉|腹瀉]]<!-- <ref name=AHFS/> -->。更嚴重副作用包含抑鬱和一些動作障礙，包含{{tsl|en|tardive dyskinesia|遲發性動作障礙}}，此類副作用又稱{{tsl|en|neuroleptic malignant syndrome|抗精神藥物惡性症候群}}<ref name=AHFS/>。本品不太建議服用超過12週<ref name=AHFS/>。本品於美國屬於[[懷孕分級|懷孕分級]]B類藥物，澳洲則規為A級，表是沒有證據表示妊娠期間用藥會導致傷害<ref name=AHFS/><ref>{{cite web|title=Prescribing medicines in pregnancy database|url=http://www.tga.gov.au/hp/medicines-pregnancy.htm#.U1Yw8Bc3tqw|work=Australian Government|accessdate=22 April 2014|date=3 March 2014}}</ref>。本品屬於{{tsl|en|dopamine-receptor antagonist|多巴胺受體拮抗劑}}<ref name=AHFS/>。

<!-- Society and culture -->
2012年，本品為美國最常開立的前100種藥物<ref>{{cite web|last=Bartholow|first=Michael|title=Top 200 Drugs of 2012|url=http://www.pharmacytimes.com/publications/issue/2013/July2013/Top-200-Drugs-of-2012|work=Pharmacy Times|accessdate=22 April 2014}}</ref>。該藥列名於[[世界卫生组织基本药物标准清单|世界卫生组织基本药物标准清单]]，為基礎公衛體系必備藥物之一<ref name=WHO19th>{{cite web|title=WHO Model List of Essential Medicines (19th List)|url=http://www.who.int/medicines/publications/essentialmedicines/EML_2015_FINAL_amended_NOV2015.pdf?ua=1|work=World Health Organization|accessdate=8 December 2016|date=April 2015}}</ref>。本品已有學名藥生產上市<ref name=AHFS/>。2014年，該藥物批發價約介於每錠{{US$}}0.003至{{US$}}0.08美金之間<ref>{{cite web|title=Metoclopramide HCL|url=http://mshpriceguide.org/en/single-drug-information/?DMFId=515&searchYear=2014|website=International Drug Price Indicator Guide|accessdate=23 August 2016}}</ref>。在美國，一個月劑量價格低於{{US$}}25<ref name=Ric2015>{{cite book|last1=Hamilton|first1=Richart|title=Tarascon Pocket Pharmacopoeia 2015 Deluxe Lab-Coat Edition|date=2015|publisher=Jones & Bartlett Learning|isbn=9781284057560|page=262}}</ref>。

==參考文獻==
{{Reflist}}

{{Propulsives}}
{{Antiemetics}}
{{Dopamine receptor modulators}}
{{Serotonin receptor modulators}}
{{portal bar|Pharmacy and pharmacology|Medicine}} 

[[Category:5-羟色胺3受体拮抗剂|Category:5-羟色胺3受体拮抗剂]]
[[Category:止吐劑|Category:止吐劑]]
[[Category:苯酰胺类|Category:苯酰胺类]]
[[Category:氯代芳烴|Category:氯代芳烴]]
[[Category:消化道促動力藥|Category:消化道促動力藥]]
[[Category:芳香醚|Category:芳香醚]]
[[Category:世界卫生组织基本药物|Category:世界卫生组织基本药物]]